How would you present the product profile of topical roflumilast to HCP colleagues who are reluctant due to poor prior experience with other PDE4 inhibitors?

Featuring Peter Lio, MD |

Clinical Assistant Professor of Dermatology Pediatrics 
Northwestern University Feinberg School of Medicine
Chicago, IL

| Published June 29, 2023

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved